Cite

HARVARD Citation

    Tazare, J. et al. (2022). Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting. Pharmacoepidemiology and drug safety. 31 (4), pp. 411-423. [Online]. 
  
Back to record